Unexpectedly given this background, we also show that PM-specific staining in the LGL associates with aggressive tumor characteristics and significantly higher risk of BCD, which would suggest that high GPR30 expression in the LGL is beneficial for tumor cells. The gene discussed is GPER1; the disease is neoplasm.